Literature DB >> 32668329

The extracellular matrix and mechanotransduction in pulmonary fibrosis.

Zhenjun Deng1, Mark W Fear2, Yu Suk Choi3, Fiona M Wood4, Amira Allahham1, Steven E Mutsaers5, Cecilia M Prêle6.   

Abstract

Pulmonary fibrosis is characterised by excessive scarring in the lung which leads to compromised lung function, serious breathing problems and in some diseases, death. It includes several lung disorders with idiopathic pulmonary fibrosis (IPF) the most common and most severe. Pulmonary fibrosis is considered to be perpetuated by aberrant wound healing which leads to fibroblast accumulation, differentiation and activation, and deposition of excessive amounts of extracellular matrix (ECM) components, in particular, collagen. Recent studies have identified the importance of changes in the composition and structure of lung ECM during the development of pulmonary fibrosis and the interaction between ECM and lung cells. There is strong evidence that increased matrix stiffness induces changes in cell function including proliferation, migration, differentiation and activation. Understanding how changes in the ECM microenvironment influence cell behaviour during fibrogenesis, and the mechanisms regulating these changes, will provide insight for developing new treatments.
Copyright © 2020. Published by Elsevier Ltd.

Entities:  

Keywords:  Collagen; Extracellular matrix; Mechanotransduction; Pulmonary fibrosis; Signal transduction

Mesh:

Substances:

Year:  2020        PMID: 32668329     DOI: 10.1016/j.biocel.2020.105802

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  14 in total

1.  Asthma and Post-Asthmatic Fibrosis: A Search for New Promising Molecular Markers of Transition from Acute Inflammation to Pulmonary Fibrosis.

Authors:  Innokenty A Savin; Andrey V Markov; Marina A Zenkova; Aleksandra V Sen'kova
Journal:  Biomedicines       Date:  2022-04-28

Review 2.  Biomechanical Force and Cellular Stiffness in Lung Fibrosis.

Authors:  Richard S Nho; Megan N Ballinger; Mauricio M Rojas; Samir N Ghadiali; Jeffrey C Horowitz
Journal:  Am J Pathol       Date:  2022-02-17       Impact factor: 5.770

3.  Mechanobiology of Pulmonary Diseases: A Review of Engineering Tools to Understand Lung Mechanotransduction.

Authors:  Caymen Novak; Megan N Ballinger; Samir Ghadiali
Journal:  J Biomech Eng       Date:  2021-11-01       Impact factor: 2.097

4.  Lung Injury and Repair in Coronavirus Disease 2019-Related Acute Lung Injury.

Authors:  Thomas R Martin
Journal:  Am J Pathol       Date:  2022-01-11       Impact factor: 4.307

Review 5.  Piezo1 Channels as Force Sensors in Mechanical Force-Related Chronic Inflammation.

Authors:  Hailin Liu; Jialing Hu; Qingcui Zheng; Xiaojin Feng; Fenfang Zhan; Xifeng Wang; Guohai Xu; Fuzhou Hua
Journal:  Front Immunol       Date:  2022-01-26       Impact factor: 7.561

6.  Baseline Stiffness Modulates the Non-Linear Response to Stretch of the Extracellular Matrix in Pulmonary Fibrosis.

Authors:  Constança Júnior; Maria Narciso; Esther Marhuenda; Isaac Almendros; Ramon Farré; Daniel Navajas; Jorge Otero; Núria Gavara
Journal:  Int J Mol Sci       Date:  2021-11-29       Impact factor: 5.923

Review 7.  Mechanotransduction Regulates the Interplays Between Alveolar Epithelial and Vascular Endothelial Cells in Lung.

Authors:  Chuyang Lin; Xiaolan Zheng; Sha Lin; Yue Zhang; Jinlin Wu; Yifei Li
Journal:  Front Physiol       Date:  2022-02-18       Impact factor: 4.566

Review 8.  Idiopathic Pulmonary Fibrosis: An Update on Pathogenesis.

Authors:  Qianru Mei; Zhe Liu; He Zuo; Zhenhua Yang; Jing Qu
Journal:  Front Pharmacol       Date:  2022-01-19       Impact factor: 5.810

Review 9.  Harnessing the ECM Microenvironment to Ameliorate Mesenchymal Stromal Cell-Based Therapy in Chronic Lung Diseases.

Authors:  Linda Elowsson Rendin; Anna Löfdahl; Måns Kadefors; Zackarias Söderlund; Emil Tykesson; Sara Rolandsson Enes; Jenny Wigén; Gunilla Westergren-Thorsson
Journal:  Front Pharmacol       Date:  2021-04-15       Impact factor: 5.810

10.  Exploring the Mechanism Whereby Sinensetin Delays the Progression of Pulmonary Fibrosis Based on Network Pharmacology and Pulmonary Fibrosis Models.

Authors:  Yong Xu; Wen-Lu Hang; Xian-Mei Zhou; Qi Wu
Journal:  Front Pharmacol       Date:  2021-06-18       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.